PSN Briefings

Plain-English cannabis industry updates — what changed, what didn’t, and why it matters.

Episode 1 • Federal Rescheduling — What Actually Changed

Latest PSN Briefs

Short, plain-English updates from the PSN desk

  • What federal rescheduling did NOT change 2 min read • Federal
  • Why state cannabis boards still control outcomes 3 min read • States
  • What operators should not assume in 2026 2 min read • Operators

[#item_full_content] Cannabis-based medicines have been widely promoted as a potential answer for people living with chronic nerve pain—but a major new review finds the evidence just isn’t there yet. After analyzing more than 20 clinical trials involving over 2,100 adults, researchers found no strong proof that cannabis products outperform placebos in relieving neuropathic pain. Even when small improvements were reported, especially with THC-CBD combinations, they weren’t large enough to make a real difference in daily life.  Read More